Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.29 USD
−9.34 M USD
0.00 USD
2.11 M
About PainReform Ltd.
Sector
CEO
Ehud Geller
Headquarters
Tel Aviv
Website
Founded
2007
ISIN
IL0011651580
FIGI
BBG00VT0S8T0
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PRFX is 2.97 USD — it has decreased by −23.08% in the past 24 hours. Watch PainReform Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PainReform Ltd. stocks are traded under the ticker PRFX.
PRFX stock has risen by 41.09% compared to the previous week, the month change is a −4.76% fall, over the last year PainReform Ltd. has showed a −93.99% decrease.
PRFX reached its all-time high on Sep 1, 2020 with the price of 471.00 USD, and its all-time low was 0.43 USD and was reached on Nov 1, 2024. View more price dynamics on PRFX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
PRFX stock is 27.49% volatile and has beta coefficient of 1.10. Track PainReform Ltd. stock price on the chart and check out the list of the most volatile stocks — is PainReform Ltd. there?
Today PainReform Ltd. has the market capitalization of 7.12 M, it has increased by 50.72% over the last week.
Yes, you can track PainReform Ltd. financials in yearly and quarterly reports right on TradingView.
PainReform Ltd. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PRFX earnings for the last quarter are −26.40 USD per share, whereas the estimation was −24.96 USD resulting in a −5.77% surprise. The estimated earnings for the next quarter are −18.96 USD per share. See more details about PainReform Ltd. earnings.
PRFX net income for the last quarter is −7.31 M USD, while the quarter before that showed −5.51 M USD of net income which accounts for −32.80% change. Track more PainReform Ltd. financial stats to get the full picture.
No, PRFX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 7.00 employees. See our rating of the largest employees — is PainReform Ltd. on this list?
Like other stocks, PRFX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PainReform Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PainReform Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PainReform Ltd. stock shows the sell signal. See more of PainReform Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.